Literature DB >> 26048975

The effect of increased lung volume in chronic obstructive pulmonary disease on upper airway obstruction during sleep.

Paolo Biselli1, Peter R Grossman2, Jason P Kirkness2, Susheel P Patil2, Philip L Smith2, Alan R Schwartz2, Hartmut Schneider3.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) exhibit increases in lung volume due to expiratory airflow limitation. Increases in lung volumes may affect upper airway patency and compensatory responses to inspiratory flow limitation (IFL) during sleep. We hypothesized that COPD patients have less collapsible airways inversely proportional to their lung volumes, and that the presence of expiratory airflow limitation limits duty cycle responses to defend ventilation in the presence of IFL. We enrolled 18 COPD patients and 18 controls, matched by age, body mass index, sex, and obstructive sleep apnea disease severity. Sleep studies, including quantitative assessment of airflow at various nasal pressure levels, were conducted to determine upper airway mechanical properties [passive critical closing pressure (Pcrit)] and for quantifying respiratory timing responses to experimentally induced IFL. COPD patients had lower passive Pcrit than their matched controls (COPD: -2.8 ± 0.9 cmH2O; controls: -0.5 ± 0.5 cmH2O, P = 0.03), and there was an inverse relationship of subject's functional residual capacity and passive Pcrit (-1.7 cmH2O/l increase in functional residual capacity, r(2) = 0.27, P = 0.002). In response to IFL, inspiratory duty cycle increased more (P = 0.03) in COPD patients (0.40 to 0.54) than in controls (0.41 to 0.51) and led to a marked reduction in expiratory time from 2.5 to 1.5 s (P < 0.01). COPD patients have a less collapsible airway and a greater, not reduced, compensatory timing response during upper airway obstruction. While these timing responses may reduce hypoventilation, it may also increase the risk for developing dynamic hyperinflation due to a marked reduction in expiratory time.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  COPD; inspiratory flow limitation; lung volume; obstructive sleep apnea; upper airway obstruction

Mesh:

Year:  2015        PMID: 26048975      PMCID: PMC4526705          DOI: 10.1152/japplphysiol.00455.2014

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  35 in total

1.  Thoracic traction on the trachea: mechanisms and magnitude.

Authors:  W B Van de Graaff
Journal:  J Appl Physiol (1985)       Date:  1991-03

2.  The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility.

Authors:  Robert L Owens; Atul Malhotra; Danny J Eckert; David P White; Amy S Jordan
Journal:  J Appl Physiol (1985)       Date:  2009-11-25

3.  Intrinsic PEEP and arterial PCO2 in stable patients with chronic obstructive pulmonary disease.

Authors:  J Haluszka; D A Chartrand; A E Grassino; J Milic-Emili
Journal:  Am Rev Respir Dis       Date:  1990-05

4.  Arterial blood gas tensions, hydrogen ion, and electroencephalogram during sleep in patients with chronic ventilatory failure.

Authors:  A G Leitch; L J Clancy; R J Leggett; P Tweeddale; P Dawson; J I Evans
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

5.  Compensatory responses to upper airway obstruction in obese apneic men and women.

Authors:  Chien-Hung Chin; Jason P Kirkness; Susheel P Patil; Brian M McGinley; Philip L Smith; Alan R Schwartz; Hartmut Schneider
Journal:  J Appl Physiol (1985)       Date:  2011-11-17

6.  The nasomaxillary complex, the mandible, and sleep-disordered breathing.

Authors:  Jee Hyun Kim; Christian Guilleminault
Journal:  Sleep Breath       Date:  2011-03-11       Impact factor: 2.816

7.  A cause of excessive daytime sleepiness. The upper airway resistance syndrome.

Authors:  C Guilleminault; R Stoohs; A Clerk; M Cetel; P Maistros
Journal:  Chest       Date:  1993-09       Impact factor: 9.410

8.  Contribution of hypoventilation to sleep oxygen desaturation in chronic obstructive pulmonary disease.

Authors:  D W Hudgel; R J Martin; M Capehart; B Johnson; P Hill
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-09

9.  Transient hypoxaemia during sleep in chronic bronchitis and emphysema.

Authors:  N J Douglas; P M Calverley; R J Leggett; H M Brash; D C Flenley; V Brezinova
Journal:  Lancet       Date:  1979-01-06       Impact factor: 79.321

10.  Symptoms and experiences in chronic bronchitis and emphysema.

Authors:  R A Kinsman; R A Yaroush; E Fernandez; J F Dirks; M Schocket; J Fukuhara
Journal:  Chest       Date:  1983-05       Impact factor: 9.410

View more
  16 in total

1.  Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease.

Authors:  Lucas M Donovan; Peter J Rise; Shannon S Carson; Laura C Feemster; Matthew F Griffith; Vishesh K Kapur; Jerry A Krishnan; Peter K Lindenauer; Richard A Mularski; Edward T Naureckas; Brian N Palen; Elizabeth C Parsons; Laura J Spece; Michael V Vitiello; David H Au
Journal:  Ann Am Thorac Soc       Date:  2017-12

2.  Predictors and outcomes of obstructive sleep apnea in patients with chronic obstructive pulmonary disease in China.

Authors:  Pan Zhang; Bi Chen; Heqing Lou; Yanan Zhu; Peipei Chen; Zongmei Dong; Xuan Zhu; Ting Li; Peian Lou
Journal:  BMC Pulm Med       Date:  2022-01-04       Impact factor: 3.317

3.  Evaluating the Relationship of Airflow Obstruction in COPD with Severity of OSA Among Patients with Overlap Syndrome.

Authors:  Nancy H Stewart; Mollie Brittan; Maureen McElligott; Michael O Summers; Kaeli Samson; Valerie G Press
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-07-14

4.  Can We Assess Pulsus Paradoxus through Polysomnography in a Patient with Chronic Obstructive Pulmonary Disease and Sleep-Disordered Breathing?

Authors:  Cesar Liendo; Ashtaad Dalal; Esther Hinds; Samreena Sara; Oleg Chernyshev; Swathi Nutakki; Jorge Rey de Castro; Andrew Chesson
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

Review 5.  Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease.

Authors:  Walter T McNicholas
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

6.  Polysomnographic features of low arousal threshold in overlap syndrome involving obstructive sleep apnea and chronic obstructive pulmonary disease.

Authors:  Yasuhiro Yamaguchi; Satomi Shiota; Yuji Kusunoki; Hironobu Hamaya; Masaki Ishii; Yuzo Kodama; Masahiro Akishita; Kozui Kida; Kazuhisa Takahashi; Takahide Nagase; Yoshinosuke Fukuchi
Journal:  Sleep Breath       Date:  2019-01-26       Impact factor: 2.816

Review 7.  Research Priorities in Pathophysiology for Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Research Statement.

Authors:  Atul Malhotra; Alan R Schwartz; Hartmut Schneider; Robert L Owens; Pamela DeYoung; MeiLan K Han; Jadwiga A Wedzicha; Nadia N Hansel; Michelle R Zeidler; Kevin C Wilson; M Safwan Badr
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

8.  Non-invasive ventilation with intelligent volume-assured pressure support versus pressure-controlled ventilation: effects on the respiratory event rate and sleep quality in COPD with chronic hypercapnia.

Authors:  Georg Nilius; Nato Katamadze; Ulrike Domanski; Maik Schroeder; Karl-Josef Franke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-03-30

Review 9.  Sleep in Chronic Obstructive Pulmonary Disease: Evidence Gaps and Challenges.

Authors:  Rachel Jen; Yanru Li; Robert L Owens; Atul Malhotra
Journal:  Can Respir J       Date:  2016-06-08       Impact factor: 2.409

10.  Age, gender, neck circumference, and Epworth sleepiness scale do not predict obstructive sleep apnea (OSA) in moderate to severe chronic obstructive pulmonary disease (COPD): The challenge to predict OSA in advanced COPD.

Authors:  Xavier Soler; Shu-Yi Liao; Jose Maria Marin; Geraldo Lorenzi-Filho; Rachel Jen; Pamela DeYoung; Robert L Owens; Andrew L Ries; Atul Malhotra
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.